Deep Vein Thrombosis (DVT): Clinical Trials

23 trials for Deep Vein Thrombosis (DVT), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 6 recruiting, 2 not yet recruiting, 1 active not recruiting. 8 Not applicable, 3 Phase 3, 3 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 5, Recruiting 2, Not yet recruiting 1
Phase 33Completed 3
Phase 43Not yet recruiting 1, Terminated 1, Unknown 1
Phase 11Completed 1

Follow Deep Vein Thrombosis (DVT): new trials by email Literature Review of Deep Vein Thrombosis (DVT) trials Research Report on Deep Vein Thrombosis (DVT)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
DECIDE-VTE Patient Decision Aid - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Not applicableNot yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre8502026-09-012026-06-24
Clinical Trial of Thrombectomy Systems
Peripheral thrombectomy system - Deep Vein Thrombosis (DVT)
Not applicableRecruitingBrosMed Medical Co., Ltd1672026-08-302026-08-07
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
Apixaban - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Phase 4Not yet recruitingJames Bayley502026-08-012026-07-20
Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
Aspiration thrombectomy system - Deep Vein Thrombosis (DVT), Thrombus in the Peripheral Venous Vasculature
RecruitingArgon Medical Devices1852026-02-042026-10-20
Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)
Progressive gait training, Standard Care (in control arm) - Deep Vein Thrombosis (DVT)
Not applicableRecruitingHvidovre University Hospital1522025-11-152026-01-23
Effectiveness and Cost-effectiveness of VTE Prevention Strategies in Gynecological Surgery
Venous Thromboembolism, Deep Vein Thrombosis (DVT)
Active not recruitingAffiliated Hospital of Nantong University2342025-11-102026-03-06
Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis
Impedance plethysmography IPG, Venous Occlusion Plethysmography VOP, Breathing and leg movement exercise - Deep Vein Thrombosis (DVT)
RecruitingTampere University402025-07-172026-06-29
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Prospective Perioperative Data Collection - Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT)
RecruitingThe First Hospital of Jilin University9002024-11-012026-02-27
To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions
Lixiana® Film Coated Tablet, Edoxaban Film Coated Tablet - Prevention of Stroke or Systemic Embolism, Deep Vein Thrombosis (DVT)
Not applicableCompletedHumanis Saglık Anonim Sirketi422024-08-302025-04-20
Improving Emergency Department Testing for Deep Vein Thrombosis
Deep Vein Thrombosis (DVT)
CompletedDr. Kerstin de Wit4582024-01-012025-05-15
COMPARISON OF WARFARIN AND RIVAROXABAN IN THE TREATMENT OF LOWER LIMB DEEP VENOUS THROMBOSIS
Rivaroxaban, Warfarin - Deep Vein Thrombosis (DVT)
Phase 1CompletedChildren Hospital and Institute of Child Health, Lahore742023-01-202025-07-22
Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery
nurse-led program (early movement, leg-sleeve squeezes, and blood tests) - Deep Vein Thrombosis (DVT)
Not applicableCompletedWest China Hospital12862021-01-012026-01-12
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
Edoxaban, Standard of Care - Venous Thromboembolism (VTE), Pulmonary Embolism
Phase 3CompletedDaiichi Sankyo2902017-03-272025-02-28
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Rivaroxaban, Apixaban, Edoxaban - Cancer, Venous Thromboembolism
Not applicableCompletedAlliance Foundation Trials, LLC.8112016-12-132023-10-03
Evaluation of Soluble Fibrin in Thrombosis Exclusion
Soluble Fibrin - Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT)
CompletedDiagnostica Stago R&D8632015-09-012019-04-18
Cancer Venous Thromboembolism (VTE)
Edoxaban, Dalteparin, Low molecular weight heparin - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Phase 3CompletedDaiichi Sankyo10462015-07-162019-03-06
Osteopathic Treatment and Deep Vein Thrombosis (DVT)
Osteopathic Treatment - Deep Vein Thrombosis (DVT)
Not applicableCompletedNova Scotia Health Authority302014-11-062023-06-15
Below Knee DVT Study
Low Dose Enoxaparin, High Dose Enoxaparin - Deep Vein Thrombosis (DVT), Blood Clots
Phase 4TerminatedOregon Health and Science University42014-09-012019-03-13
Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Rivaroxaban (Xarelto, BAY59-7939), Recommended VTE pharmacological treatments according to international guidelines - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)
CompletedBayer19872014-06-272019-08-29
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Enoxaparin Sodium Injection 30 mg BID, Enoxaparin Sodium Injection 40 mg QD - Trauma, Surgery
Phase 4UnknownOregon Health and Science University6062014-02-012024-04-03

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Venous Thrombosis (23)  ·  Pulmonary Embolism (12)  ·  Venous Thromboembolism (11)  ·  Thrombosis (4)  ·  Thromboembolism (3)  ·  Disease (2)  ·  Neoplasms (2)  ·  Bone Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Lung Neoplasms (1)  ·  Motor Activity (1)  ·  Vascular Diseases (1)  ·  Wounds and Injuries (1)

Broader conditions

Cardiovascular Diseases (22)  ·  Embolism and Thrombosis (22)  ·  Vascular Diseases (22)  ·  Thrombosis (19)  ·  Lung Diseases (13)  ·  Respiratory Tract Diseases (13)  ·  Embolism (12)  ·  Thromboembolism (10)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Behavior (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Neoplasms (1)

Interventions

edoxaban (5)  ·  Enoxaparin (4)  ·  Warfarin (4)  ·  Rivaroxaban (3)  ·  Dalteparin (2)  ·  Fondaparinux (2)  ·  Heparin (2)  ·  Heparin, Low-Molecular-Weight (2)  ·  Standard of Care (2)  ·  apixaban (2)  ·  BID protein, human (1)  ·  Dabigatran (1)  ·  Hematologic Tests (1)  ·  Manipulation, Osteopathic (1)  ·  Plethysmography, Impedance (1)

Sponsors

Daiichi Sankyo (3)  ·  Oregon Health and Science University (2)  ·  Affiliated Hospital of Nantong University (1)  ·  Alliance Foundation Trials, LLC. (1)  ·  Argon Medical Devices (1)  ·  Bayer (1)  ·  BrosMed Medical Co., Ltd (1)  ·  Children Hospital and Institute of Child Health, Lahore (1)  ·  Diagnostica Stago R&D (1)  ·  Dr. Kerstin de Wit (1)  ·  Hawler Medical University (1)  ·  Humanis Saglık Anonim Sirketi (1)  ·  Hvidovre University Hospital (1)  ·  James Bayley (1)  ·  Johannes Gutenberg University Mainz (1)

Countries

United States (8)  ·  Canada (5)  ·  China (5)  ·  France (4)  ·  Denmark (3)  ·  Germany (3)  ·  Hungary (3)  ·  India (3)  ·  Netherlands (3)  ·  Russia (3)  ·  Singapore (3)  ·  South Korea (3)  ·  Taiwan (3)  ·  Turkey (Türkiye) (3)  ·  Ukraine (3)

Top investigators

Ariana K. Jawad, C.A.B.OG (1)  ·  Darlene D MacLeod, BscN DOMP (1)  ·  Deborah Schrag, MD MPH (1)  ·  Helle Juul-Larsen, Ph.D. (1)  ·  Isabelle Mahe, MD, PhD (1)  ·  Izzet Altinas, M.D. (1)  ·  Jean Connors, MD (1)  ·  Mahabad S. Ali, Diploma (1)  ·  Marc Rodger, MD MSc FRCPC (1)  ·  Martin A Schreiber, MD (1)  ·  Martin Schreiber, MD (1)  ·  Mette Merete Pedersen, Ph.D. (1)

Results publications

PMID 21861537, PMID 23991658, PMID 26133379, PMID 26179767, PMID 26271200, PMID 27476789, PMID 27570090, PMID 28689179, PMID 29231094, PMID 29248859, PMID 32217063, PMID 34172290, PMID 37266947, PMID 37855029, PMID 40925065, PMID 41195787

NIH funding

2014 (1), 2016 (1)